It has been reported that mucosal inflammation in patients with IBD and experimental models of intestinal inflammation is accompanied by elevated levels of activated NF-κB, particularly P65, P50, and c-Rel [26, 27]. This evidence concerns the gene REL and inflammatory bowel disease.